Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11712460
Methods of treating chronic disorders with complement inhibitors
granted -
US 11708364
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 11708329
Inhibitors of the WNT/beta-catenin pathway
granted -
US 11708333
Human plasma kallikrein inhibitors
granted -
US 11708332
Human plasma kallikrein inhibitors
granted -
US 11708347
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11702400
Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors
granted -
US 11702415
Crystalline hydrate of a JAK inhibitor compound
granted -
US 11701361
p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an immune response to exogenous immunogens
granted -
US 11702411
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
granted -
US 11702389
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 11701354
Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors
granted -
US 11697648
Fused pyrimidine pyridinone compounds as JAK inhibitors
granted -
US 11690850
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11691987
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 11690915
Ras inhibitors
granted -
US 11691974
3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors
granted -
US 11691989
Macrocyclic indoles as Mcl-1 inhibitors
granted -
US 11685744
CDK inhibitors and their use as pharmaceuticals
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11685721
Human plasma kallikrein inhibitors
granted -
US 11685749
C26-linked rapamycin analogs as mTOR inhibitors
granted -
US 11679112
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 11679101
Anhydrous compositions of mTOR inhibitors and methods of use
granted